IM Cannabis (IMCC) Net Cash Flow (2020 - 2026)
IM Cannabis' (IMCC) quarterly Net Cash Flow came in at $177197.0 in Q1 2026, down 84.02% year-on-year from $1.1 million in Q1 2025, and down 49.98% quarter-over-quarter from $354240.6 in Q4 2025.
IM Cannabis (IMCC) Net Cash Flow (2020 - 2026) Analysis & Trends
IM Cannabis' Net Cash Flow history runs 7 years deep, the most recent figure standing at $177197.0 for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 84.02% year-over-year to $177197.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a 25.52% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, up 129.76% from the prior year.
- Net Cash Flow retreated to $177197.0 in Q1 2026 per IMCC's latest filing, from $354240.6 in the prior quarter.
- Across five years, Net Cash Flow topped out at $3.1 million in Q3 2023 and bottomed at -$3.5 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$28236.3 (2022), against an average of -$85344.5.
- Biggest YoY gain for Net Cash Flow was 307.1% in 2023; the steepest drop was 10580.51% in 2023.
- Year by year, Net Cash Flow stood at -$2.2 million in 2022, then jumped by 70.83% to -$649329.4 in 2023, then soared by 61.41% to -$250547.2 in 2024, then surged by 241.39% to $354240.6 in 2025, then plunged by 49.98% to $177197.0 in 2026.
- Per Business Quant, the three latest IMCC Net Cash Flow figures stand at $177197.0 (Q1 2026), $354240.6 (Q4 2025), and $2.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 177,196.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 177,196.98 |
| Mar 31, 2026 | 177,196.98 |
| Dec 31, 2025 | 354,240.62 |
| Dec 31, 2025 | 354,240.62 |
| Sep 30, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | -309,614.66 |
| Jun 30, 2025 | -309,614.66 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | -250,547.20 |
| Dec 31, 2024 | -250,547.20 |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -649,329.41 |
| Dec 31, 2023 | -649,329.41 |